New developments in the management of COPD: clinical utility of indacaterol 75 μg

Chronic obstructive pulmonary disease (COPD) is a global health challenge and a major cause of mortality worldwide. Bronchodilators, particularly long-acting β(2)-agonists and long-acting antimuscarinic agents, used singly or in combination, aim to improve lung function, reduce symptoms, prevent exa...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Steiropoulos, Paschalis, Archontogeorgis, Kostas, Nena, Evangelia, Bouros, Demosthenes
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2013
Teme:
Review
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3862584/
https://ncbi.nlm.nih.gov/pubmed/24353414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S24940
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki